
Speaker
Join us for a roundtable discussion on the updated 2026 ACC/AHA Dyslipidemia Guidelines and their implications for cardiovascular risk assessment.

Speaker

Speaker

Moderator
MyOme's Chief Medical Officer
Featuring cardiology experts Akl Fahed, MD, MPH, and Michael Levin, MD, this session will explore how polygenic risk scores are being incorporated into everyday clinical decision-making - from identifying at-risk patients earlier to refining treatment strategies beyond traditional risk factors.
Moderated by MyOme's Chief Medical Officer, Akash Kumar, MD, PhD, this conversation offers practical, real-world perspective for clinicians looking to apply the latest guideline updates and genomic risk tools in patient care.
Save your spot